chr10-110810372-G-C

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001134363.3(RBM20):​c.1801-11G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0269 in 1,549,418 control chromosomes in the GnomAD database, including 876 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 82 hom., cov: 32)
Exomes 𝑓: 0.027 ( 794 hom. )

Consequence

RBM20
NM_001134363.3 intron

Scores

2
Splicing: ADA: 0.00003465
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.296
Variant links:
Genes affected
RBM20 (HGNC:27424): (RNA binding motif protein 20) This gene encodes a protein that binds RNA and regulates splicing. Mutations in this gene have been associated with familial dilated cardiomyopathy. [provided by RefSeq, Apr 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 10-110810372-G-C is Benign according to our data. Variant chr10-110810372-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 43977.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-110810372-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0925 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RBM20NM_001134363.3 linkc.1801-11G>C intron_variant Intron 7 of 13 ENST00000369519.4 NP_001127835.2 Q5T481
RBM20XM_017016103.3 linkc.1636-11G>C intron_variant Intron 7 of 13 XP_016871592.1
RBM20XM_017016104.3 linkc.1417-11G>C intron_variant Intron 7 of 13 XP_016871593.1
RBM20XM_047425116.1 linkc.1417-11G>C intron_variant Intron 7 of 13 XP_047281072.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RBM20ENST00000369519.4 linkc.1801-11G>C intron_variant Intron 7 of 13 1 NM_001134363.3 ENSP00000358532.3 Q5T481

Frequencies

GnomAD3 genomes
AF:
0.0265
AC:
4033
AN:
152150
Hom.:
80
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0264
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0214
Gnomad ASJ
AF:
0.0204
Gnomad EAS
AF:
0.0267
Gnomad SAS
AF:
0.0995
Gnomad FIN
AF:
0.0341
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0215
Gnomad OTH
AF:
0.0350
GnomAD3 exomes
AF:
0.0350
AC:
5478
AN:
156494
Hom.:
156
AF XY:
0.0388
AC XY:
3216
AN XY:
82944
show subpopulations
Gnomad AFR exome
AF:
0.0280
Gnomad AMR exome
AF:
0.0181
Gnomad ASJ exome
AF:
0.0225
Gnomad EAS exome
AF:
0.0288
Gnomad SAS exome
AF:
0.0942
Gnomad FIN exome
AF:
0.0368
Gnomad NFE exome
AF:
0.0232
Gnomad OTH exome
AF:
0.0314
GnomAD4 exome
AF:
0.0270
AC:
37697
AN:
1397150
Hom.:
794
Cov.:
30
AF XY:
0.0291
AC XY:
20034
AN XY:
689216
show subpopulations
Gnomad4 AFR exome
AF:
0.0256
Gnomad4 AMR exome
AF:
0.0182
Gnomad4 ASJ exome
AF:
0.0226
Gnomad4 EAS exome
AF:
0.0246
Gnomad4 SAS exome
AF:
0.0941
Gnomad4 FIN exome
AF:
0.0379
Gnomad4 NFE exome
AF:
0.0217
Gnomad4 OTH exome
AF:
0.0310
GnomAD4 genome
AF:
0.0265
AC:
4042
AN:
152268
Hom.:
82
Cov.:
32
AF XY:
0.0282
AC XY:
2103
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.0264
Gnomad4 AMR
AF:
0.0214
Gnomad4 ASJ
AF:
0.0204
Gnomad4 EAS
AF:
0.0266
Gnomad4 SAS
AF:
0.0998
Gnomad4 FIN
AF:
0.0341
Gnomad4 NFE
AF:
0.0215
Gnomad4 OTH
AF:
0.0403
Alfa
AF:
0.0151
Hom.:
9
Bravo
AF:
0.0243
Asia WGS
AF:
0.100
AC:
349
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Oct 18, 2012
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 17, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

1801-11G>C in intron 7 of RBM20: This variant is not expected to have clinical s ignificance because it has been identified in 2.6% (67/2532) of European America n chromosomes and 3.3% (23/702) of African American chromosomes from a broad pop ulation by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/ ; dbSNP rs12572941) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Dilated cardiomyopathy 1DD Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
16
DANN
Benign
0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000035
dbscSNV1_RF
Benign
0.024
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12572941; hg19: chr10-112570130; API